294 related articles for article (PubMed ID: 12694648)
1. Biological markers in pT1 and pT2 ovarian cancer with lymph node metastases.
Concin N; Hefler L; van Bavel J; Mueller-Holzner E; Zeimet A; Daxenbichler G; Speiser P; Hacker N; Marth C
Gynecol Oncol; 2003 Apr; 89(1):9-15. PubMed ID: 12694648
[TBL] [Abstract][Full Text] [Related]
2. Lymph node metastasis in stage I epithelial ovarian cancer.
Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinicopathologic significance of CD44v6/CD24 in ovarian serous carcinomas].
Wang A; Lu L; Wang Y; Sun Y; Zhang Y; Guo C; Gu Y; Liu A
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):20-4. PubMed ID: 24713244
[TBL] [Abstract][Full Text] [Related]
5. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors.
Takeshima N; Hirai Y; Umayahara K; Fujiwara K; Takizawa K; Hasumi K
Gynecol Oncol; 2005 Nov; 99(2):427-31. PubMed ID: 16112718
[TBL] [Abstract][Full Text] [Related]
6. Lymph node metastasis in grossly apparent stages I and II epithelial ovarian cancer.
Nomura H; Tsuda H; Susumu N; Fujii T; Banno K; Kataoka F; Tominaga E; Suzuki A; Chiyoda T; Aoki D
Int J Gynecol Cancer; 2010 Apr; 20(3):341-5. PubMed ID: 20375794
[TBL] [Abstract][Full Text] [Related]
7. Relevance of pelvic and para-aortic node metastases in early-stage ovarian cancer.
Bachmann C; Krämer B; Brucker SY; Stäbler A; Fend F; Wallwiener D; Grischke EM; Rothmund R
Anticancer Res; 2014 Nov; 34(11):6735-8. PubMed ID: 25368283
[TBL] [Abstract][Full Text] [Related]
8. [Risk factors for retroperitoneal lymph node metastasis in ovarian cancer].
Akiyama M; Takahashi Y; Hirose M; Yamamoto Y; Ishiguro T; Noda Y
Nihon Sanka Fujinka Gakkai Zasshi; 1994 Mar; 46(3):260-4. PubMed ID: 8133137
[TBL] [Abstract][Full Text] [Related]
9. Incidence and Pattern of Spread of Lymph Node Metastasis in Patients With Low-grade Serous Ovarian Cancer.
Wafa M; Braicu EI; Muallem MZ; Richter R; Taube E; Sehouli J; Grabowski JP
Anticancer Res; 2019 Oct; 39(10):5617-5621. PubMed ID: 31570458
[TBL] [Abstract][Full Text] [Related]
10. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
[TBL] [Abstract][Full Text] [Related]
11. Lymph node involvement in epithelial ovarian cancer: sites and risk factors in a series of 355 patients.
Fournier M; Stoeckle E; Guyon F; Brouste V; Thomas L; MacGrogan G; Floquet A
Int J Gynecol Cancer; 2009 Nov; 19(8):1307-13. PubMed ID: 20009882
[TBL] [Abstract][Full Text] [Related]
12. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
13. Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker.
Wang J; Liu Q; Zhou X; He Y; Guo Q; Shi Q; Eriksson S; Zhou J; He E; Skog S
Tumour Biol; 2017 Jun; 39(6):1010428317706479. PubMed ID: 28651488
[TBL] [Abstract][Full Text] [Related]
14. Stage- and Histologic Subtype-Dependent Frequency of Lymph Node Metastases in Patients with Epithelial Ovarian Cancer Undergoing Systematic Pelvic and Paraaortic Lymphadenectomy.
Heitz F; Harter P; Ataseven B; Heikaus S; Schneider S; Prader S; Bommert M; Fisseler-Eckhoff A; Traut A; du Bois A
Ann Surg Oncol; 2018 Jul; 25(7):2053-2059. PubMed ID: 29633097
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological factors of pelvic lymph nodes involvement in advanced serous ovarian cancer.
Piatek S; Golawski K; Panek G; Bidzinski M; Wielgos M
Ginekol Pol; 2020; 91(2):68-72. PubMed ID: 32141051
[TBL] [Abstract][Full Text] [Related]
16. Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses.
Bogani G; Tagliabue E; Ditto A; Signorelli M; Martinelli F; Casarin J; Chiappa V; Dondi G; Leone Roberti Maggiore U; Scaffa C; Borghi C; Montanelli L; Lorusso D; Raspagliesi F
Gynecol Oncol; 2017 Oct; 147(1):61-65. PubMed ID: 28779965
[TBL] [Abstract][Full Text] [Related]
17. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Factors Affecting Lymph Node Metastasis in Clinical Stage I-II Epithelial Ovarian Cancer.
Erdem B; Yüksel IT; Peker N; Ulukent SC; Aşıcıoğlu O; Özaydin IY; Ülker V; Akbayir O
Oncol Res Treat; 2018; 41(7-8):444-448. PubMed ID: 29975960
[TBL] [Abstract][Full Text] [Related]
19. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
[TBL] [Abstract][Full Text] [Related]
20. Lymphovascular space invasion and Ki67 as predictors of lymph node metastasis in primary low grade serous ovarian cancer.
Grabowski JP; Glajzer J; Richter R; Plett H; Muallem MZ; Braicu EI; Taube E; Sehouli J
Int J Gynecol Cancer; 2021 Jan; 31(1):98-103. PubMed ID: 33127866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]